Scientists from Yale University have identified a particular immune response pathway that leads to severe illness and death in people infected by the SARS-CoV-2 virus.
The research is published on bioRxiv and was conducted by Esen Sefik et al.
Researchers have known that once the COVID-19 virus infects the lungs, it can trigger what has been called a “cytokine storm,” or an overactive immune response that leads to deadly inflammation in the lungs.
In the study, the team examined the effects of SARS-CoV-2 infection in mice engineered to have a human immune system.
To their surprise, they found that immune cells themselves, not just epithelial cells lining the lung, can harbor the virus.
When the body detects the virus in these cells, inflammasomes, part of the immune system’s early warning system, produce and release cytokines that prompt these immune cells to commit suicide in an attempt to abort infection.
However, the cytokines also recruit even more inflammatory cells to the lungs from the blood, which drives a vicious cycle that leads to pneumonia.
In the mouse model of COVID-19, researchers were able to rescue infected mice from pneumonia by blocking the NLPR3 inflammasome pathway.
With the inflammasome pathway blocked, immune system cells were still infected. But they were no longer inflammatory and therefore could not contribute to damaging levels of inflammation, researchers found.
One byproduct of this rescue, however, is that the cells no longer die and as a consequence release more virus.
Nonetheless, blockade of the inflammasome pathway along with antiviral treatment could provide a way to treat COVID-19 pneumonia and prevent severe cases of COVID-19.
Although there are no approved drugs that block the NLPR3 pathway, several pharmaceutical and biotech companies are developing them.
Sign up for our newsletter for more information about this topic.
If you care about COVID, please read studies that Vitamin D3 could help people fight COVID-19 and other infections, and this drug may relieve painful ‘long covid’ symptoms.
For more information about COVID, please see recent studies about new antiviral drug combo highly effective against COVID-19, and results showing this existing drug can save damaged lungs in COVID-19.
Copyright © 2022 Knowridge Science Report. All rights reserved.
